172
Views
8
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLEImaging, Diagnosis, Prognosis

Pigment Epithelium-Derived Factor Expression in Colorectal Cancer Patients

, , , &
Pages 872-877 | Published online: 26 May 2010

REFERENCES

  • Ferrara, N.; Davis-Smith, T. The biology of vascular endothelial growth factor. Endocr Rev 1997, 18, 4–25.
  • Nakamura, M.; Abe, Y.; Tokunaga, T. Pathological significance of vascular endothelial growth factor A isoform expression in human cancer. Pathol Int 2002, 52, 331–339.
  • George, M.L.; Tutton, M.G.; Janssen, F.; Arnaout, A.; Abulafi, A.M.; Eccles, S.A.; Swift, R.I. VEGF-A, VEGF-C and VEGF-D in colorectal cancer progression. Neoplasia 2001, 3, 420–427.
  • Rak, J.; Klement, G. Impact of oncogenes and tumor suppressor genes on deregulation of hemostasis and angiogenesis in cancer. Cancer Metastasis Rev 2000, 19, 93–96.
  • Dawson, D.W.; Volpert, O.V.; Gillis, P.; Crawford, S.E.; Xu, H.; Benedict, W.; Bouck, N.P. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999, 285, 245–248.
  • Tombran-Tink, J.; Johnson, L.V. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 1989, 30, 1700–1707.
  • Mori, K.; Duh, E.; Gehlbach, P.; Ando, A.; Takahashi, K.; Pearlman, J.; Mori, K.; Yang, H.S.; Zack, D.J.; Ettyreddy, D.; Brough, D.E.; Wei, L.L.; Campochiaro, P.A. Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 2001, 188, 253–263.
  • Stellmach, V.; Crawford, S.E.; Zhou, W.; Bouck, N. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. PNAS 2001, 98, 2593–2597.
  • Bhutto, I.A.; McLeod, D.S.; Hasegawa, T.; Kim, S.Y.; Merges, C.; Tong, P.; Lutty, G.A. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res 2006, 82, 99–110.
  • Tombran-Tink, J. The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci 2005, 10, 2131–2149.
  • Fernandez-Garcia, N.I.; Volpert, O.V.; Jimenez, B. Pigment epithelium-derived factor as a multifunctional antitumor factor. J Mol Med 2007, 85, 15–22.
  • Guan, M.; Yam, H.F.; Su, B.; Chan, K.P.; Pang, C.P.; Liu, W.W.; Zhang, W.Z.; Lu, Y. Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol 2003, 56,277–282.
  • Doll, J.A.; Stellmach, V.M.; Bouck, N.P.; Bergh, A.R.J.; Chung, L.; Abramson, L.P.; Cornwell, M.L.; Prins, M.R.; Borensztajn, J.; Crawford, S.E. Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 2003, 9, 774–780.
  • Cai, J.; Parr, C.; Watkins, G.; Jiang, W.G.; Boulton, M. Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin Cancer Res 2006, 12, 3510–3517.
  • Zhang, L.; Chen, J.; Ke, Y.; Mansel, R.E.; Jiang, W.G. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Int J Mol Med 2006, 17, 937–944.
  • Yamagishi, S.; Nakamura, K.; Inoue, H.; Takeuchi, M. Met72Thr polymorphism of pigment epithelium-derived factor gene and susceptibility to age-related macular degeneration. Med Hypothesis 2005, 64, 1202–1204.
  • Lin, J.M.; Wan, L.; Tsai, Y.Y.; Lin, H.J.; Tsai, Y.; Lee, C.C.; Tsai, C.H.; Tseng, S.H.; Tsai, F.J. Pigment epithelium-derived factor gene Met72Thr polymorphism is associated with increased risk of wet age-related macular degeneration. Am J Ophtalmol 2008, 145, 716–721.
  • Diaz, R.; Pena, C.; Silva, J.; Lorenzo, Y.; Garcia, V.; Garcia, J.M.; Sanchez, A.; Espinosa, P.; Yuste, R.; Bonilla, F.; Dominguez, G. p73 isoforms affect VEGF, VEGF165b downregulation as a marker of poor prognosis. Int J Cancer 2008, 123, 1060–1067.
  • Uhlén, M.; Björling, E.; Agaton, C.; Szigyarto, C.A.; Amini, B.; Andersen, E.; Andersson, A.C.; Angelidou, P.; Asplund, A.; Asplund, C.; Berglund, L.; Bergström, K.; Brumer, H.; Cerjan, D.; Ekström, M.; Elobeid, A.; Eriksson, C.; Fagerberg, L.; Falk, R.; Fall, J.; Forsberg, M.; Björklund, M.G.; Gumbel, K.; Halimi, A.; Hallin, I.; Hamsten, C.; Hansson, M.; Hedhammar, M.; Hercules, G.; Kampf, C.; Larsson, K.; Lindskog, M.; Lodewyckx, W.; Lund, J.; Lundeberg, J.; Magnusson, K.; Malm, E.; Nilsson, P.; Odling, J.; Oksvold, P.; Olsson, I.; Oster, E.; Ottosson, J.; Paavilainen, L.; Persson, A.; Rimini, R.; Rockberg, J.; Runeson, M.; Sivertsson, A.; Sköllermo, A.; Steen, J.; Stenvall, M.; Sterky, F.; Strömberg, S.; Sundberg, M.; Tegel, H.; Tourle, S.; Wahlund, E.; Waldén, A.; Wan, J.; Wernérus, H.; Westberg, J.; Wester, K.; Wrethagen, U.; Xu, L.L.; Hober, S.; Pontén, F. A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005, 4(12), 1920–1932.
  • Zhang, S.X.; Wang, J.J.; Gao, G.; Shao, C.; Mott, R.; Ma, J.X. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006, 20, 323–325.
  • Chung, Y.C.; Chang, Y.F. Serum interleukin-6 levels reflect the disease status of colorectal cancer. J Surg Oncol 2003, 83, 222–226.
  • Yamagishi, S.; Adachi, H.H.; Abe, A.; Yashiro, T.; Enomoto, M.; Furuki, K.; Hino, A.; Jinnouchi, Y.; Takenaka, K.; Matsui, T.; Nakamura, K.; Imaizumi, T. Elevated serum levels of pigment epithelium-derived factor (PEDF) in the metabolic syndrome. J Clin Endocrinol Metab 2006, 91, 2447–2450.
  • Tombran-Tink, J.; Mazuruk, K.; Rodriguez, I.R.; Chung, D.; Linker, T.; Englander, E.; Chader, G.J. Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 1996, 2, 11.
  • Ponsuksili, S.; Murani, E.; Schellander, K.; Schwerin, M.; Wimmers, K. Identification of functional candidate genes for body composition by expression analyses and evidencing impact by association analysis and mapping. Biochim Biophys Acta 2005, 1730, 31–40.
  • Matrisian, L.M.; Wright, J.; Newell, K.; Witty, J.P. Matrix-degrading metalloproteinases in tumor progression. Princess Takamatsu Symp 1994, 24, 152–161.
  • Roeb, E.; Dietrich, C.G.; Winograd, R.; Arndt, M.; Breuer, B.; Fass, J.; Schumpelick, V.; Matern, S. Activity and cellular origin of gelatinases in patients with colon and rectal carcinoma differential activity of matrix metalloproteinase-9. Cancer 2001, 92, 2680– 2691.
  • Notari, L.; Miller, A.; Martinez, A.; Amaral, J.; Ju, M.; Robinson, G.; Smith, L.E.; Becerra, S.P. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest Ophthalmol Vis Sci 2005, 46, 2736–2747.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.